Kina Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: GLP-1 weight care alongside HRT, from board-certified physicians
Kina scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
then $199/mo ongoing
Tirzepatide
then $249/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Billed separately
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms. Its GLP-1 program provides compounded semaglutide and tirzepatide from $179/month (plus a $50 physician consult; $0 membership), prescribed and monitored by board-certified physicians at Arora Health & Aesthetics. It carries verifiable LegitScript certification, is FSA/HSA eligible, ships free, and is cancel-anytime. Compounded medications are not FDA-approved; the pharmacy is not named.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Kina
Editorial score · methodology
Try Ageless
Best for: lowest-tier compounded GLP-1 in injection, troche and sublingual forms
Editorial score · methodology
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Kina at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $169/mo
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Kina
Each dimension is scored algorithmically from Kina’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $199/mo, Kina runs about 18% above the $169 median for GLP-1 providers, and the first month drops to $169.
Effectiveness25%
8.8/10Kina offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.9/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
8.0/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-15).
Accessibility10%
7.2/10Kina's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.6/10Kina provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Kina review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Kina
We walked Kina’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a brief ~2-minute intake about your symptoms and goals.
- 2A licensed clinician reviews it and prescribes a plan if appropriate.
- 3Receive free shipping from a licensed pharmacy with ongoing support.
- $179/mo price displayed prominently in the hero before any intake.
- States 'No memberships, no hidden fees,' 'No insurance required,' and 'FSA/HSA eligible.'
- Only 'Cancel anytime' is mentioned; no specific refund terms provided.
- Free shipping stated repeatedly.
- Prescribing done by clinicians at Arora Health & Aesthetics, licensed in your state.
GLP-1 medications Kina offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Kina offers
Beyond GLP-1s, Kina also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
$199/month standing, $169 for a first month. A $25 physician consultation fee is covered, not added.
Ready to get started?
Plans and promotions change often — check Kina's current pricing and active discounts before you decide.
What we like
- Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
- Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
- Verifiable LegitScript certification (seal ID 50917967)
- GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
- Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake
Watch-outs
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Built for women navigating menopause — less tailored if that is not your situation
- A separate $50 physician consultation fee applies on top of the medication price
- The compounding pharmacy partner is not named, and the full list of served states is not published
Is Kina worth it? Our verdict
Kina positions itself around one thing: GLP-1 weight care alongside HRT, from board-certified physicians. New patients start at $169/month for the first month, but the price settles at $199/month after that — so the headline is an intro offer, not the standing rate.
On top of the prescription itself, Kina points to Menopause-focused, LegitScript Verified, and FSA/HSA eligible.
How much Kina actually costs
- Compounded semaglutide — $169 first month, then $199/month
- Compounded tirzepatide — $169 first month, then $249/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so Kina's standing rate sits at the premium end. The first-month discount is a great way to start cheaply, but price out the ongoing rate against a flat-rate provider before you commit long term.
For a direct comparison, RNK Health runs semaglutide and tirzepatide from $197/month — worth pricing against Kina before you commit.
Medications: what Kina prescribes
Kina prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Kina is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Sunlight will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Kina is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $169 intro price steps up to $199/month once the first month is behind you. Use that window to confirm the medication works for you, then re-check the ongoing math before you settle in. If you're comparison-shopping, HumeCare+ is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Kina scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with Kina?
Starting at $169/month. See current pricing and start your free consultation.
Kina might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Kina review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Kina's current pricing
Plans start at $169/month. Start your free consultation to check eligibility and today's price.